scispace - formally typeset
M

Mark K. Shigenaga

Researcher at Children's Hospital Oakland Research Institute

Publications -  62
Citations -  19303

Mark K. Shigenaga is an academic researcher from Children's Hospital Oakland Research Institute. The author has contributed to research in topics: DNA damage & Oxidative stress. The author has an hindex of 37, co-authored 62 publications receiving 18631 citations. Previous affiliations of Mark K. Shigenaga include Boston Children's Hospital & University of California, Berkeley.

Papers
More filters
Journal ArticleDOI

Oxidants, antioxidants, and the degenerative diseases of aging

TL;DR: It is argued that this damage to DNA, protein, and lipid is a major contributor to aging and to degenerative diseases of aging such as cancer, cardiovascular disease, immune-system decline, brain dysfunction, and cataracts.
Journal ArticleDOI

Oxidative damage and mitochondrial decay in aging

TL;DR: Evidence supports the suggestion that age-associated accumulation of mitochondrial deficits due to oxidative damage is likely to be a major contributor to cellular, tissue, and organismal aging.
Journal ArticleDOI

Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine.

TL;DR: The results suggest that the age-dependent accumulation of oh8dG residues observed in DNA from liver, kidney, and intestine is principally due to the slow loss of DNA nuclease activity; however, an increase in the rate of oxidative DNA damage cannot be ruled out.
Journal ArticleDOI

Ascorbic acid protects against endogenous oxidative DNA damage in human sperm.

TL;DR: Dietary AA protects human sperm from endogenous oxidative DNA damage that could affect sperm quality and increase risk of genetic defects, particularly in populations with low AA such as smokers.
Journal ArticleDOI

gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention.

TL;DR: It is suggested that gamma-tocopherol may contribute significantly to human health in ways not recognized previously, and this possibility should be further evaluated, especially considering that high doses of alpha-tocaperol deplete plasma and tissue gamma-Tocopherol, in contrast with supplementation withGamma-CEHC, which increases both.